Leucine

Leucine is an AI-powered pharmaceutical manufacturing software company providing solutions for quality, manufacturing, and laboratory operations. Founded in 2015 by Vivek Gera (CEO) and Mustaq Singh Bijral, the company focuses on automating cleaning validation and GMP compliance processes for pharmaceutical manufacturers.

Headquartered in Wilmington, Delaware with development operations in Rajasthan, India, Leucine serves 30+ pharmaceutical companies across 300+ manufacturing facilities in 10 countries including the US, India, Brazil, Mexico, and UAE. Leucine markets its flagship product, CLEEN, as the "#1 cleaning validation software for pharma," automating the entire cleaning validation lifecycle.

Notable customers include Cipla, one of India's largest pharmaceutical companies, which featured CLEEN in their annual report. Leucine raised $7M in Series A funding in October 2023, led by Ecolab.

Leucine is pharma-focused with 100% of solutions designed for pharmaceutical manufacturing. Serves 30+ pharmaceutical companies across 300+ manufacturing facilities globally. Notable customer Cipla (major Indian pharmaceutical company) featured CLEEN in their annual report.

Target customers include new biotech firms and pharmaceutical giants requiring FDA and EMA compliant cleaning validation. Products designed for GMP compliance with automated HBEL-based residue calculations, worst-case product selection, and audit-ready documentation. Leucine markets the platform as trusted by "top global pharma" for cleaning lifecycle automation and regulatory compliance.

Series A company with $7-9.6M total funding raised across 3 rounds. Latest funding: $7M Series A in October 2023, led by Ecolab with participation from Pravega Ventures and Techstars. Ecolab (NYSE: ECL, $14B market cap) is a global hygiene and cleaning leader.

100% growth rate achieved with 300% increase in user base reported in 2023. Number of facilities using Leucine grew 100% year-over-year. Revenue not publicly disclosed. Company targets both new biotech firms and pharmaceutical giants, with focus on digital transformation of cleaning validation processes.

CLEEN is the flagship product - cleaning validation software automating the entire cleaning lifecycle from design to qualification to monitoring. Key capabilities include automated HBEL (Health-Based Exposure Limits) calculations, worst-case product selection with 20+ configurable risk attributes, auto-generated validation protocols and reports, and real-time residue trend monitoring.

Platform integrates residue data from LIMS for comprehensive validation reports. Includes features for MACO calculations, cleaning verification, changeovers, hold-times, and sampling with rich images. AI-powered recommendations optimize cleaning methods and resources. Leucine reports a 70% improvement in validation cycle times after one year of use.

Additional products in Leucine's Compliance Cloud suite for broader pharmaceutical manufacturing compliance beyond cleaning validation.

Strategic investor Ecolab (NYSE: ECL) - global leader in water, hygiene, and infection prevention solutions with $14B+ market cap. Ecolab led Leucine's $7M Series A in October 2023.

Platform integrates with ERP systems and LIMS for residue data. Works with existing pharmaceutical manufacturing technology stacks. Techstars accelerator participation provides startup ecosystem connections. Pravega Ventures provides additional venture backing.

Implementation support for CLEEN deployment across pharmaceutical manufacturing facilities. Training and onboarding for cleaning validation digitalization. Customer success programs for ongoing optimization.

Users report fast implementation times with intuitive interface. Responsive customer support highlighted in user feedback. The platform serves 300+ facilities across 10 countries. Specific support hours, SLA terms, and certification programs are undisclosed.

10-year track record since founding in 2015. Leucine markets CLEEN as the "#1 Cleaning Validation Software for Pharma" on LinkedIn. Cipla featured CLEEN in its annual report. TechCrunch covered the Series A funding round.

Ecolab is a strategic investor with pharmaceutical industry relationships. Leucine is a Techstars accelerator alumnus and is listed on LinkedIn Products, Capterra, and SourceForge. The company's positioning is "AI for Pharma."

The website includes comprehensive cleaning validation content, blogs, and regulatory guidelines resources. Listed on Capterra and LinkedIn Products. SourceForge listing available. TechCrunch covered the $7M Series A funding.

Content marketing is active, with cleaning validation blogs covering FDA, EMA, MHRA, and WHO guidelines. Demo and trial availability through website. Social media presence on LinkedIn with product page. Leucine markets itself as "proactive cleaning validation software trusted by Fortune 500 Pharma" and a "global leader for digitalizing cleaning compliance procedures."